China Gene Therapy Trial Reports 2nd Death, Leaving 1-Patient Study With Sole Participant Dead
Updated
Updated · Retraction Watch · Aug 8
China Gene Therapy Trial Reports 2nd Death, Leaving 1-Patient Study With Sole Participant Dead
3 articles · Updated · Retraction Watch · Aug 8
Summary
A second death has been reported in a gene therapy trial in China, according to Retraction Watch’s roundup citing an update to the study record.
ClinicalTrials.gov now says the trial’s only patient died, making the 1-patient study’s sole participant the second reported fatality tied to the trial.
The new disclosure follows a death case Retraction Watch said it revealed last month, indicating another fatal outcome has now been formally acknowledged.
The report adds to wider scrutiny of research integrity and trial transparency highlighted in the same roundup, which tracked retractions, misconduct probes and publication concerns.